SBAVC | Sociedade Brasileira de AVC
@SBAVC1
Perfil Oficial da SBAVC
Great work by @ChrissiTunkl et al, about this important topic - #telestroke networks around the globe. Congrats to all team! And to our brazilian colleagues @GiseleSampaioS @LeoAugCarbonera journals.sagepub.com/doi/epub/10.11…
Vai perder?! As controvérsias são várias na #neurovascular, e o congresso AVC2025 deste ano estará recheado delas! Venha logo! Inscreva-se em avc2025.com.br e venha a Floripa ver o top do AVC com especialistas incríveis!!!! A programação já está online!
Vacinas salvam vidas, e previnem demência... Estudo publicado na Nature.
Not just shingles vaccine, but also RSV vaccine reduces the risk of dementia, which highlights the benefit of revving up the immune system in older individuals nature.com/articles/s4154…
Uma ótima revisão do tema, motivo de interconsultas do neurhospitalista. A great review of this interesting topic, present in many evaluations of the common practice of the neurohospitalist. ahajournals.org/doi/full/10.11…
This adds to 6 others recent ones previously reviewed by @pranavrajpurkar and me nytimes.com/2025/02/02/opi… erictopol.substack.com/p/when-doctors…
Another example today of A.I. performing better than physicians with access to A.I. acpjournals.org/doi/10.7326/AN… @AnnalsofIM
Perspective on the general concepts of statistical interaction and a series of general considerations that can guide the interpretation of regression results and interaction testing. ahajournals.org/doi/full/10.11…
Anti-amyloid therapies, despite a controversial topic, is coming... #ARIA is a hot topic regarding this treatment. Aside many questions about its real benefits in the course of the disease, and risks, this is an issue we, vascular neurologists, must know! pubs.rsna.org/doi/full/10.11…
ICYMI – here are all 19 LBS trial results presented at #ISC25.
Important insights from a large RWE study 👇👇👇@epHealth_
#STROKE: Despite the availability of rehabilitation centers in Brazil, geographical access is still suboptimal. As a means of improving the clinical pathway, the use of large real-world databases may be needed for real needs assessments. @JuliaMachline ahajrnls.org/41FdupX
Tudo sobre Tecnologia, #IA aplicada à Neurologia Vascular, #bigdata .... Estamos preparando um programa recheado de novidades na área!!!! Acessem avc2025.com.br, e inscreva-se!!!!!!! #AVC2025
Programação show, em BREVE!!!!!! Acesse avc2025.com.br, e inscreva-se!!!!!!! #AVC2025
A Comissão Científica já está preparando um programa INCRÍVEL!!!!! Acesse avc2025.com.br, e inscreva-se!!!!!!! #AVC2025
Acesse avc2025.com.br, e inscreva-se!!!!!!! #AVC2025
Always disappointed when cilostazol is discussed in ICAD #stroke prevention in the US: discussed as an antiplatelet alternative to P2Y12i. NO! It’s barely an antithrombotic; no added🩸risk. Benefit is likely ⬆️ perfusion, antiproliferative. Should view as an added element #ISC25
‼️Practice changing update from #ISC25 Every comprehensive stroke center needs to address their plans to offer adjunct intra-arterial thrombolytics after a successful thrombectomy.
Dr Huo presents POSITIVE results from Angel-TNK administering adjunct IA TNK LVO pts with eTICI 2b50 to 3, primary outcome of mRS 0-1. #ISC25 🧑⚕️Note the details on administration of IA TNK 👍does not seem to increase sICH risk 🛑limitations: 🇨🇳, open-label, excl IVT recipients
#HOPE results on IV #alteplase between 4.5 and 24 hours by Min Lou #ISC25 @AHAScience @StrokeAHA_ASA @SVINJournal @SVINSociety @YNIScommittee @SNISinfo